About Panacro
About Us
Corporate Culture
Our History
Team
Honors
Subsidiaries
Full Service
PRE-IND Application
IND Application & Preparations
Study Conduct
NDA
Post-marketing Study
Our Advantages
Experience
Cutting Edge Services
IDMC Team
Project Operation System
QA System
Digital Services
Vaccine
Human Resources
Talent Philosophy
Training & Development
Employee Activities
Jobs Available
News Center
Company News
Policies & Regulations
Partners
Contact us
EN
EN
CN
Menu
Search
Home
About Panacro
About Us
Corporate Culture
Our History
Team
Honors
Subsidiaries
Full Service
PRE-IND Application
IND Application & Preparations
Study Conduct
NDA
Post-marketing Study
Our Advantages
Experience
Cutting Edge Services
IDMC tTeam
Project Operation System
QA System
Digital Services
Vaccine
Human Resources
Talent Philosophy
Training & Development
Employee Activities
Jobs Available
News Center
Company News
Policies & Regulations
Partners
Contact Us
EN
Our Advantages
Experience
Cutting Edge Services
IDMC Team
Project Operation System
Quality Assurance System
Digital Services
Vaccine
Experience
46%,phase I
29%,phase III
24%,phase II
1%,phase IV
49%,tumor
8%,infection
15%,autoimmunity
4%,ophthalmology
12%,metabolism
2%,pain
10%,breathing